Tokyo-listed GNI Group Co., Ltd. has finalized a definitive agreement to purchase 100 percent of Ayumi Pharmaceutical Holdings Co., Ltd. from a Blackstone-led investor consortium for approximately ¥44.8 billion, expanding its domestic market presence.
A definitive agreement has been reached for GNI Group Co., Ltd. to acquire full ownership of Ayumi Pharmaceutical Holdings Co., Ltd. from investment funds managed by Blackstone and other institutional shareholders. According to official corporate regulatory filings, the transformational transaction values the target company at approximately ¥44.8 billion and is projected to propel GNI Group's consolidated fiscal 2026 revenue to an estimated ¥65.2 billion. GNI Group is a cross-Pacific biopharmaceutical enterprise specializing in fibrosis and oncology therapies, while Ayumi Pharmaceutical operates as a prominent domestic specialty drug maker controlling over 80 percent of Japan's acetaminophen market through its flagship Calonal brand.
For the fiscal year ending March 2026, Ayumi posted consolidated revenue of ¥38.5 billion and an operating profit of ¥6.2 billion. This strategic transaction directly impacts the East Asian healthcare, investment banking, and ethical pharmaceuticals industries. By absorbing Ayumi’s commercial distribution infrastructure, GNI Group establishes an immediate, large-scale platform to accelerate the commercialization of biosimilars and pipeline therapeutics in Japan.
On an industry policy level, the acquisition allows the combined entity to diversify its geographical revenue exposure across Japan, China, and the United States, cushioning against localized regulatory pricing pressures. For global pharmaceutical investors and corporate decision-makers, this exit marks a highly successful conclusion to Blackstone's inaugural control private equity deployment in the Japanese healthcare sector.
The deal illustrates a broader macroeconomic trend where specialized biotechnology firms leverage robust cross-border asset consolidation to acquire established, cash-generative commercial networks, thereby accelerating their path toward international scale.
About GlobeNewsInfo
GlobeNewsInfo.com is a business news platform providing latest updates on global business developments, projects, and contract opportunities across diverse sectors and regions. The platform is designed to serve as a trusted source of information for companies, investors, and professionals worldwide.